Kelsey Goodwin Score: 39
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+53.7%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
56%
5 W / 4 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
100%
5 W / 0 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 5 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 5 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
43%
3 W / 4 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
43%
3 W / 4 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
100%
2 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jan 16, 2026 |
Cg Oncology Inc.
CGON
|
BUY |
$70.00
Est. +32%
|
$53.07 | $75.50 |
Target Met
|
$59.56
+12.2%
|
| Jan 16, 2026 |
Janux Therapeutics Inc
JANX
|
BUY |
$30.00
Est. +119%
|
$13.72 | $16.60 |
Pending
|
$13.56
-1.2%
|
| Jan 16, 2026 |
Black Diamond Therapeutics Inc
BDTX
|
BUY |
$8.00
Est. +200%
|
$2.67 | $3.97 |
Pending
|
$1.75
-34.5%
|
| Jan 07, 2026 |
ORIC Pharmaceuticals Inc
ORIC
|
BUY |
$22.00
Est. +170%
|
$8.14 | $14.25 |
Pending
|
$8.27
+1.6%
|
| Oct 27, 2025 |
Nuvalent Inc - Ordinary Shares - Class A
NUVL
|
BUY |
$128.00
Est. +37%
|
$93.39 | $123.62 |
Pending
|
$123.25
+32.0%
|
| Aug 19, 2025 |
Revolution Medicines Inc
RVMD
|
BUY |
$75.00
Est. +105%
|
$36.56 | $166.50 |
Target Met
|
$153.87
+320.9%
|
| Aug 19, 2025 |
Summit Therapeutics Inc
SMMT
|
SELL |
$21.00
Est. +18%
|
$25.71 | $12.55 (Low) |
Target Met
|
$14.01
+45.5%
|
| Aug 19, 2025 |
Cg Oncology Inc.
CGON
|
BUY |
$55.00
Est. +110%
|
$26.14 | $75.50 |
Target Met
|
$59.56
+127.9%
|
| Sep 16, 2024 |
Nuvalent Inc - Ordinary Shares - Class A
NUVL
|
SELL |
$105.00
Est. +5%
|
$110.25 | $55.54 (Low) |
Target Met
|
$123.25
-11.8%
|
Cg Oncology Inc.
CGON
Jan 16, 2026
Signal & Target
BUY
$70.00
Start Price
$53.07
Best Price (1Y)
$75.50
Current Price
$59.56
Return
+12.2%
Janux Therapeutics Inc
JANX
Jan 16, 2026
Signal & Target
BUY
$30.00
Start Price
$13.72
Best Price (1Y)
$16.60
Current Price
$13.56
Return
-1.2%
Black Diamond Therapeutics Inc
BDTX
Jan 16, 2026
Signal & Target
BUY
$8.00
Start Price
$2.67
Best Price (1Y)
$3.97
Current Price
$1.75
Return
-34.5%
ORIC Pharmaceuticals Inc
ORIC
Jan 07, 2026
Signal & Target
BUY
$22.00
Start Price
$8.14
Best Price (1Y)
$14.25
Current Price
$8.27
Return
+1.6%
Nuvalent Inc - Ordinary Shares - Class A
NUVL
Oct 27, 2025
Signal & Target
BUY
$128.00
Start Price
$93.39
Best Price (1Y)
$123.62
Current Price
$123.25
Return
+32.0%
Revolution Medicines Inc
RVMD
Aug 19, 2025
Signal & Target
BUY
$75.00
Start Price
$36.56
Best Price (1Y)
$166.50
Current Price
$153.87
Return
+320.9%
Summit Therapeutics Inc
SMMT
Aug 19, 2025
Signal & Target
SELL
$21.00
Start Price
$25.71
Best Price (1Y)
$12.55
Current Price
$14.01
Return
+45.5%
Cg Oncology Inc.
CGON
Aug 19, 2025
Signal & Target
BUY
$55.00
Start Price
$26.14
Best Price (1Y)
$75.50
Current Price
$59.56
Return
+127.9%
Nuvalent Inc - Ordinary Shares - Class A
NUVL
Sep 16, 2024
Signal & Target
SELL
$105.00
Start Price
$110.25
Best Price (1Y)
$55.54
Current Price
$123.25
Return
-11.8%